Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer

Background: Currently, the diagnosis of non-organ-confined bladder cancer (NOCBCa) has a very poor prognosis. For patients with NOCBCa, treatments such as radical cystectomy (RC) and systemic chemotherapy have shown survival benefits. However, the relative survival benefits of trimodal therapy (TMT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yadong, Jie, Xiaoliang, Zhang, Aihong, Zhang, Wentao, Wang, Ruiliang, Zhang, Junfeng, Mao, Shiyu, Wu, Yuan, Wang, Longsheng, Zhang, Ziwei, Yan, Yang, Wang, Ping, Yao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909817/
https://www.ncbi.nlm.nih.gov/pubmed/31867271
http://dx.doi.org/10.3389/fonc.2019.01315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909817/
https://www.ncbi.nlm.nih.gov/pubmed/31867271
http://dx.doi.org/10.3389/fonc.2019.01315

Ejemplares similares